Clinical trials
Terminated Phase 1 trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 21 |
| Pfizer | 5 |
| Eli Lilly and Company | 3 |
| Amgen | 2 |
| Bayer | 2 |
| National Cancer Centre, Singapore | 2 |
| National University Hospital, Singapore | 2 |
| Alnylam Pharmaceuticals | 1 |
| BerGenBio ASA | 1 |
| Biogen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 10 |
| Colorectal Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Carcinoma, Renal Cell | 3 |
| Esophageal Squamous Cell Carcinoma | 3 |
| Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Lung Neoplasms | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.